You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 284 No. 8, August 23, 2000 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Medical News & Perspectives
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (42)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Widely Used Spermicide May Increase, Not Decrease, Risk of HIV Transmission

Joan Stephenson, PhD

JAMA. 2000;284:949.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Durban, South Africa—Hopes that a product already widely used as a spermicide could help protect women against HIV infection were dashed when results from a large phase 3 study reported here at the XIII International AIDS Conference indicated that the product appears to increase transmission of the virus.

Many women are unable to protect themselves against HIV transmission because they are unable to negotiate consistent condom use by male partners. In recent years, HIV/AIDS experts have cited the need for a "stealth" microbicide that women could use, with or without their partner's consent, to reduce their risk of HIV infection and other sexually transmitted infections. Although a variety of potential microbicides are now under study, researchers reasoned that a substance already approved as a spermicide might offer some protection against infection and would have the advantage of having already undergone safety testing for that indication.

In . . . [Full Text of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

In vitro testing of rationally designed spermicides for selectively targeting human sperm in vagina to ensure safe contraception
Jain et al.
Hum Reprod 2009;24:590-601.
ABSTRACT | FULL TEXT  

Integrating Multidimensional HIV Prevention Programs Into Healthcare Settings
Temoshok and Wald
Psychosom. Med. 2008;70:612-619.
ABSTRACT | FULL TEXT  

Novel disulphide esters of carbothioic acid as potent, non-detergent spermicides with low toxicity to Lactobacillus and HeLa cells in vitro
Jain et al.
Hum Reprod 2007;22:708-716.
ABSTRACT | FULL TEXT  

Two Novel Vaginal Microbicides (Polystyrene Sulfonate and Cellulose Sulfate) Inhibit Gardnerella vaginalis and Anaerobes Commonly Associated with Bacterial Vaginosis
Simoes et al.
Antimicrob. Agents Chemother. 2002;46:2692-2695.
ABSTRACT | FULL TEXT  

Efficacy and Safety of a New Vaginal Contraceptive Antimicrobial Formulation Containing High Molecular Weight Poly(Sodium 4-Styrenesulfonate)
Zaneveld et al.
Biol. Reprod. 2002;66:886-894.
ABSTRACT | FULL TEXT  

When Should the Public Be Informed of the Results of Medical Research?
Holtz et al.
JAMA 2001;286:2944-2945.
FULL TEXT  

RASA, a recombinant single-chain variable fragment (scFv) antibody directed against the human sperm surface: implications for novel contraceptives
Norton et al.
Hum Reprod 2001;16:1854-1860.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2000 American Medical Association. All Rights Reserved.